Veronique Dehlinger

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Veronique Dehlinger is an author at Eli Lilly (United States) specializing in allosteric agonists, negative allosteric modulators, and allosteric regulation.

Publications per year

2013–2013

Publications

Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator

Junliang Hao, Veronique Dehlinger, Adam M. Fivush et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–1 of 1